Agricultural Biotechnology: Emerging Technologies and Global Markets
July 30, 2012
Wellesley, Mass. – According to a new technical market research report, AGRICULTURAL BIOTECHNOLOGY: EMERGING TECHNOLOGIES AND GLOBAL MARKETS (BIO100A) from BCC Research (www.bccresearch.com), the global market for agricultural biotechnology was valued at $13.7 billion in 2011.This figure is projected to reach $14.4 billion in 2012 and nearly $24.8 billion in 2017, increasing at a five-year compound annual growth rate (CAGR) of 11.4%.
The agricultural biotechnology market can be split into three segments: transgenic seeds, synthetic biology-enabled products, and tools.
The transgenic seeds segment is projected to increase from $14.1 billion in 2012 to $20.4 billion in 2017, a CAGR of 7.6%.
As a segment, synthetic biology-enabled products are expected to jump from nearly $200 million in 2012 to nearly $3.9 billion in 2017, a CAGR of 81%.
The segment made up of tools, expected to be worth $80.5 million in 2012, should be valued at $465.2 million in 2017, a CAGR of 42%.
Key factors that affect the agricultural biotechnology industry include a growing demand for food, more frequent occurrences of severe environmental threats, continuing innovations in genomics tools, and development of novel seed types.
The biotechnology tools market, which is made up of DNA sequencing services, biochips, and RNA interference assays, is a small but key part of the industry. Tools such as DNA sequencing enable better insights into gene function and regulation, which leads to better agricultural products.
Several market shifts are occurring in the industry, which are positive for future growth. In transgenic seeds, leading countries continue to have high adoption rates for the main crop types and companies are developing new seed traits. Transgenic seeds for new crops are being developed, including for rice and wheat, and these new markets will foster growth.
This report will help its audience:
- Analyze key technologies and products in the agricultural biotechnology market
- Determine present and future market status and projected growth from 2012 through 2017
- Examine strategic alliances, industry structures and competitive dynamics
- Receive information regarding relevant patents and patent strategy
- Profile companies involved in the agricultural biotechnology industry.
This report will be of particular interest to agriculture, chemicals, enzymes, bioenergy, and biotechnology companies, as well as suppliers of genomics tools, synthetic biology, RNA interference, and DNA sequencing products. It also will be of high interest to professionals within governments and regulatory agencies to help them understand the scope and pace of transgenic seeds as they continue to expand in the market.
Agricultural Biotechnology: Emerging Technologies and Global Markets( BIO100A )
Publish Date: Jul 2012
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum